Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2021 Earnings

28OctConfirmed

Q1 2021

Q2 2021

Q3 2021

Q4 2021

-11.21

-10.26

-9.32

-8.37

Details

Expected EPS

-8.80542

Actual EPS

-9.256979999999999

Surprise EPS

-0.45

Surprise Percent

+5.13%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -9.256979999999999 per share for Q4 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.